Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 18, 2017 09:00 ET | Source: Therapeutic Solutions International, Inc.

Therapeutic Solutions International Announces Exclusive Patent License Agreement to innaMune with its Subsidiary Emvolio, Inc.

OCEANSIDE, CA--(Marketwired - May 18, 2017) - Therapeutics Solutions International, Inc. (OTC PINK: TSOI) announced today an exclusive licensing agreement with its subsidiary, Emvolio, Inc. The...
May 16, 2017 09:00 ET | Source: Therapeutic Solutions International, Inc.

Therapeutic Solutions files Patent on Blood Derived Innate Immune System Stimulator

OCEANSIDE, CA--(Marketwired - May 16, 2017) - Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today the filing of a patent for a novel blood derived stimulator of innate immune...
May 10, 2017 09:00 ET | Source: Therapeutic Solutions International, Inc.

Therapeutic Solutions International Announces Exclusive Patent License Agreement with its Subsidiary Emvolio, Inc.

OCEANSIDE, CA--(Marketwired - May 10, 2017) - Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today an exclusive licensing agreement with its subsidiary Emvolio, Inc. The...
May 09, 2017 09:00 ET | Source: Therapeutic Solutions International, Inc.

Therapeutic Solutions files new Patent on Targeting the Tumor Microenvironment through Nutraceutical Based Immunoadjuvants

OCEANSIDE, CA--(Marketwired - May 09, 2017) - Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today the filing of a patent for a nutraceutical product called "Cancer Metabolic...
May 01, 2017 10:53 ET | Source: Therapeutic Solutions International, Inc.

Therapeutic Solutions International Announces Appointment of Dr. Thomas E. Ichim to its Subsidiary Emvolio, Inc.

OCEANSIDE, CA--(Marketwired - May 01, 2017) - Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today that the Board of Directors of its majority owned subsidiary, Emvolio, Inc....
April 24, 2017 09:00 ET | Source: Therapeutic Solutions International, Inc.

Therapeutic Solutions International's Subsidiary OmniBiome, Inc. Announces First Oral Microbiome Therapy for Periodontal Disease

OCEANSIDE, CA--(Marketwired - April 24, 2017) - Therapeutic Solutions International, Inc.'s (OTC PINK: TSOI) subsidiary, OmniBiome, Inc., announced today the successful development of an oral...
April 12, 2017 09:45 ET | Source: Therapeutic Solutions International, Inc.

Therapeutic Solutions International's Subsidiary, Emvolio, Inc., Files Investigational New Drug Application for StemVacs Cancer Immunotherapy

OCEANSIDE, CA--(Marketwired - April 12, 2017) - Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today the filing of an Investigational New Drug (IND) application by its...
April 10, 2017 11:44 ET | Source: Therapeutic Solutions International, Inc.

Therapeutic Solutions International Announces Filing of new Immunotherapy Patent and Exclusive Patent License Agreement with Subsidiary Emvolio, Inc.

OCEANSIDE, CA--(Marketwired - April 10, 2017) - Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today the filing of a new patent and exclusive licensing agreement with majority...
February 06, 2017 08:30 ET | Source: Therapeutic Solutions International, Inc.

Therapeutic Solutions Receives Allowance on Patent Claim from the US Patent Office Covering ProJuvenol(R) Active Ingredient Pterostilbene in Cancer Immunotherapies

OCEANSIDE, CA --(Marketwired - February 06, 2017) - Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today that the United States Patent and Trademark Office allowed issuance of...
July 11, 2016 09:00 ET | Source: Therapeutic Solutions International, Inc.

Therapeutic Solutions International Reports Augmentation of Cancer Immunotherapy Using Pterostilbene

OCEANSIDE, CA--(Marketwired - July 11, 2016) - Therapeutic Solutions International, Inc., (OTC PINK: TSOI) reported novel data supporting the use of pterostilbene, a natural analog of resveratrol...